XML 41 R49.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Condensed Consolidating Financial Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract] |
Condensed Consolidating Statement of Operations |
| For the Year Ended December 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 20.7 |  |  | $ | 2,425.5 |  |  | $ | 1,221.7 |  |  | $ | 1,074.1 |  |  | $ | (137.0 | ) |  | $ | 4,605.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 59.6 |  |  | 1,176.5 |  |  | 608.7 |  |  | 748.9 |  |  | (20.7 | ) |  | 2,573.0 |
Other operating expenses | 45.0 |  |  | 351.8 |  |  | 189.3 |  |  | 88.4 |  |  | (50.9 | ) |  | 623.6 |
Occupancy costs | 2.1 |  |  | 100.8 |  |  | 27.5 |  |  | 17.3 |  |  | (65.4 | ) |  | 82.3 |
Supplies | — |  |  | 98.0 |  |  | 49.3 |  |  | 20.6 |  |  | — |  |  | 167.9 |
General and administrative expenses | 160.0 |  |  | — |  |  | — |  |  | 87.0 |  |  | — |  |  | 247.0 |
Depreciation and amortization | 19.9 |  |  | 106.8 |  |  | 54.9 |  |  | 37.1 |  |  | — |  |  | 218.7 |
Total operating expenses | 286.6 |  |  | 1,833.9 |  |  | 929.7 |  |  | 999.3 |  |  | (137.0 | ) |  | 3,912.5 |
Loss on early extinguishment of debt | 7.7 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 7.7 |
Interest expense and amortization of debt discounts and fees | 131.0 |  |  | 24.7 |  |  | 5.6 |  |  | 28.4 |  |  | (30.0 | ) |  | 159.7 |
Other income | (32.3 | ) |  | (21.1 | ) |  | (7.1 | ) |  | — |  |  | 30.0 |  |  | (30.5 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (5.1 | ) |  | (0.4 | ) |  | (1.2 | ) |  | — |  |  | (6.7 | )
Equity in net income of consolidated affiliates | (492.6 | ) |  | (67.0 | ) |  | — |  |  | — |  |  | 559.6 |  |  | — |
Management fees | (160.8 | ) |  | 117.8 |  |  | 43.0 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 281.1 |  |  | 542.3 |  |  | 250.9 |  |  | 47.6 |  |  | (559.6 | ) |  | 562.3 |
Provision for income tax (benefit) expense | (78.2 | ) |  | 140.3 |  |  | 40.3 |  |  | 13.5 |  |  | — |  |  | 115.9 |
Income from continuing operations | 359.3 |  |  | 402.0 |  |  | 210.6 |  |  | 34.1 |  |  | (559.6 | ) |  | 446.4 |
Loss from discontinued operations, net of tax | (0.6 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (0.6 | )
Net income | 358.7 |  |  | 402.0 |  |  | 210.6 |  |  | 34.1 |  |  | (559.6 | ) |  | 445.8 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (83.3 | ) |  | (3.8 | ) |  | — |  |  | (87.1 | )
Net income attributable to Encompass Health | $ | 358.7 |  |  | $ | 402.0 |  |  | $ | 127.3 |  |  | $ | 30.3 |  |  | $ | (559.6 | ) |  | $ | 358.7 |
Comprehensive income | $ | 358.7 |  |  | $ | 402.0 |  |  | $ | 210.6 |  |  | $ | 34.1 |  |  | $ | (559.6 | ) |  | $ | 445.8 |
Comprehensive income attributable to Encompass Health | $ | 358.7 |  |  | $ | 402.0 |  |  | $ | 127.3 |  |  | $ | 30.3 |  |  | $ | (559.6 | ) |  | $ | 358.7 |
| For the Year Ended December 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 21.0 |  |  | $ | 2,351.8 |  |  | $ | 1,118.9 |  |  | $ | 915.9 |  |  | $ | (130.3 | ) |  | $ | 4,277.3 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 49.5 |  |  | 1,132.2 |  |  | 550.4 |  |  | 643.3 |  |  | (21.4 | ) |  | 2,354.0 |
Other operating expenses | 37.9 |  |  | 344.3 |  |  | 177.4 |  |  | 75.3 |  |  | (49.8 | ) |  | 585.1 |
Occupancy costs | 1.9 |  |  | 95.7 |  |  | 25.4 |  |  | 14.1 |  |  | (59.1 | ) |  | 78.0 |
Supplies | — |  |  | 95.8 |  |  | 44.9 |  |  | 18.0 |  |  | — |  |  | 158.7 |
General and administrative expenses | 161.0 |  |  | — |  |  | — |  |  | 59.2 |  |  | — |  |  | 220.2 |
Depreciation and amortization | 14.3 |  |  | 108.2 |  |  | 47.6 |  |  | 29.6 |  |  | — |  |  | 199.7 |
Government, class action, and related settlements | 52.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 52.0 |
Total operating expenses | 316.6 |  |  | 1,776.2 |  |  | 845.7 |  |  | 839.5 |  |  | (130.3 | ) |  | 3,647.7 |
Interest expense and amortization of debt discounts and fees | 124.2 |  |  | 22.6 |  |  | 2.2 |  |  | 23.5 |  |  | (25.2 | ) |  | 147.3 |
Other income | (22.4 | ) |  | (1.0 | ) |  | (3.5 | ) |  | (0.5 | ) |  | 25.2 |  |  | (2.2 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (7.1 | ) |  | (0.4 | ) |  | (1.2 | ) |  | — |  |  | (8.7 | )
Equity in net income of consolidated affiliates | (465.6 | ) |  | (63.4 | ) |  | — |  |  | — |  |  | 529.0 |  |  | — |
Management fees | (153.1 | ) |  | 114.0 |  |  | 39.1 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 221.3 |  |  | 510.5 |  |  | 235.8 |  |  | 54.6 |  |  | (529.0 | ) |  | 493.2 |
Provision for income tax (benefit) expense | (69.9 | ) |  | 136.6 |  |  | 38.4 |  |  | 13.8 |  |  | — |  |  | 118.9 |
Income from continuing operations | 291.2 |  |  | 373.9 |  |  | 197.4 |  |  | 40.8 |  |  | (529.0 | ) |  | 374.3 |
Income from discontinued operations, net of tax | 1.1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1.1 |
Net income | 292.3 |  |  | 373.9 |  |  | 197.4 |  |  | 40.8 |  |  | (529.0 | ) |  | 375.4 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (77.8 | ) |  | (5.3 | ) |  | — |  |  | (83.1 | )
Net income attributable to Encompass Health | $ | 292.3 |  |  | $ | 373.9 |  |  | $ | 119.6 |  |  | $ | 35.5 |  |  | $ | (529.0 | ) |  | $ | 292.3 |
Comprehensive income | $ | 292.3 |  |  | $ | 373.9 |  |  | $ | 197.4 |  |  | $ | 40.8 |  |  | $ | (529.0 | ) |  | $ | 375.4 |
Comprehensive income attributable to Encompass Health | $ | 292.3 |  |  | $ | 373.9 |  |  | $ | 119.6 |  |  | $ | 35.5 |  |  | $ | (529.0 | ) |  | $ | 292.3 |
| For the Year Ended December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 21.3 |  |  | $ | 2,252.5 |  |  | $ | 1,006.4 |  |  | $ | 759.8 |  |  | $ | (126.1 | ) |  | $ | 3,913.9 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 34.7 |  |  | 1,088.7 |  |  | 508.9 |  |  | 543.3 |  |  | (21.0 | ) |  | 2,154.6 |
Other operating expenses | 32.8 |  |  | 324.8 |  |  | 160.2 |  |  | 62.4 |  |  | (48.6 | ) |  | 531.6 |
Occupancy costs | 1.9 |  |  | 93.7 |  |  | 23.0 |  |  | 11.4 |  |  | (56.5 | ) |  | 73.5 |
Supplies | — |  |  | 94.2 |  |  | 41.7 |  |  | 13.4 |  |  | — |  |  | 149.3 |
General and administrative | 143.7 |  |  | — |  |  | — |  |  | 28.0 |  |  | — |  |  | 171.7 |
Depreciation and amortization | 8.8 |  |  | 106.6 |  |  | 44.7 |  |  | 23.7 |  |  | — |  |  | 183.8 |
Total operating expenses | 221.9 |  |  | 1,708.0 |  |  | 778.5 |  |  | 682.2 |  |  | (126.1 | ) |  | 3,264.5 |
Loss on early extinguishment of debt | 10.7 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 10.7 |
Interest expense and amortization of debt discounts and fees | 130.5 |  |  | 23.2 |  |  | 2.5 |  |  | 19.2 |  |  | (21.0 | ) |  | 154.4 |
Other (income) loss | (21.7 | ) |  | 0.2 |  |  | (3.6 | ) |  | — |  |  | 21.0 |  |  | (4.1 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (6.9 | ) |  | (0.4 | ) |  | (0.7 | ) |  | — |  |  | (8.0 | )
Equity in net income of consolidated affiliates | (342.1 | ) |  | (39.0 | ) |  | — |  |  | — |  |  | 381.1 |  |  | — |
Management fees | (145.0 | ) |  | 109.5 |  |  | 35.5 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 167.0 |  |  | 457.5 |  |  | 193.9 |  |  | 59.1 |  |  | (381.1 | ) |  | 496.4 |
Provision for income tax (benefit) expense | (104.5 | ) |  | 182.6 |  |  | 66.8 |  |  | 0.9 |  |  | — |  |  | 145.8 |
Income from continuing operations | 271.5 |  |  | 274.9 |  |  | 127.1 |  |  | 58.2 |  |  | (381.1 | ) |  | 350.6 |
Loss from discontinued operations, net of tax | (0.4 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (0.4 | )
Net income | 271.1 |  |  | 274.9 |  |  | 127.1 |  |  | 58.2 |  |  | (381.1 | ) |  | 350.2 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (68.7 | ) |  | (10.4 | ) |  | — |  |  | (79.1 | )
Net income attributable to Encompass Health | $ | 271.1 |  |  | $ | 274.9 |  |  | $ | 58.4 |  |  | $ | 47.8 |  |  | $ | (381.1 | ) |  | $ | 271.1 |
Comprehensive income | $ | 271.0 |  |  | $ | 274.9 |  |  | $ | 127.1 |  |  | $ | 58.2 |  |  | $ | (381.1 | ) |  | $ | 350.1 |
Comprehensive income attributable to Encompass Health | $ | 271.0 |  |  | $ | 274.9 |  |  | $ | 58.4 |  |  | $ | 47.8 |  |  | $ | (381.1 | ) |  | $ | 271.0 |
Condensed Consolidating Balance Sheet |
| As of December 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 6.0 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 94.8 |
Restricted cash | — |  |  | — |  |  | 57.4 |  |  | — |  |  | — |  |  | 57.4 |
Accounts receivable | — |  |  | 280.4 |  |  | 125.6 |  |  | 100.1 |  |  | — |  |  | 506.1 |
Prepaid expenses and other current assets | 64.3 |  |  | 35.4 |  |  | 9.3 |  |  | 7.8 |  |  | (19.3 | ) |  | 97.5 |
Total current assets | 118.0 |  |  | 321.0 |  |  | 198.3 |  |  | 137.8 |  |  | (19.3 | ) |  | 755.8 |
Property and equipment, net | 133.4 |  |  | 1,246.0 |  |  | 551.2 |  |  | 28.7 |  |  | — |  |  | 1,959.3 |
Operating lease right-of-use assets | 10.1 |  |  | 171.5 |  |  | 86.5 |  |  | 43.7 |  |  | (35.3 | ) |  | 276.5 |
Goodwill | — |  |  | 912.2 |  |  | 323.0 |  |  | 1,070.0 |  |  | — |  |  | 2,305.2 |
Intangible assets, net | 17.7 |  |  | 101.7 |  |  | 65.3 |  |  | 291.6 |  |  | — |  |  | 476.3 |
Deferred income tax assets | 27.2 |  |  | 11.1 |  |  | 0.1 |  |  | — |  |  | (35.5 | ) |  | 2.9 |
Other long-term assets | 53.6 |  |  | 85.4 |  |  | 151.6 |  |  | 14.1 |  |  | — |  |  | 304.7 |
Intercompany notes receivable | 737.8 |  |  | — |  |  | — |  |  | — |  |  | (737.8 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 3,155.4 |  |  | 523.6 |  |  | — |  |  | — |  |  | (3,679.0 | ) |  | — |
Total assets | $ | 4,253.2 |  |  | $ | 3,372.5 |  |  | $ | 1,376.0 |  |  | $ | 1,585.9 |  |  | $ | (4,506.9 | ) |  | $ | 6,080.7 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 17.0 |  |  | $ | 10.4 |  |  | $ | 3.8 |  |  | $ | 8.1 |  |  | $ | — |  |  | $ | 39.3 |
Current operating lease liabilities | 1.3 |  |  | 21.9 |  |  | 16.0 |  |  | 12.1 |  |  | (10.9 | ) |  | 40.4 |
Accounts payable | 9.8 |  |  | 56.5 |  |  | 24.3 |  |  | 4.0 |  |  | — |  |  | 94.6 |
Accrued payroll | 34.8 |  |  | 76.2 |  |  | 40.4 |  |  | 59.1 |  |  | — |  |  | 210.5 |
Accrued interest payable | 30.4 |  |  | 2.0 |  |  | — |  |  | — |  |  | — |  |  | 32.4 |
Other current liabilities | 82.2 |  |  | 30.5 |  |  | 68.8 |  |  | 141.6 |  |  | (19.3 | ) |  | 303.8 |
Total current liabilities | 175.5 |  |  | 197.5 |  |  | 153.3 |  |  | 224.9 |  |  | (30.2 | ) |  | 721.0 |
Long-term debt, net of current portion | 2,670.6 |  |  | 305.4 |  |  | 41.6 |  |  | 5.7 |  |  | — |  |  | 3,023.3 |
Long-term operating lease liabilities | 9.0 |  |  | 153.9 |  |  | 73.6 |  |  | 31.9 |  |  | (24.6 | ) |  | 243.8 |
Intercompany notes payable | — |  |  | — |  |  | — |  |  | 737.8 |  |  | (737.8 | ) |  | — |
Self-insured risks | 19.3 |  |  | — |  |  | 97.9 |  |  | — |  |  | — |  |  | 117.2 |
Other long-term liabilities | 26.6 |  |  | 12.2 |  |  | 2.4 |  |  | 37.0 |  |  | (35.5 | ) |  | 42.7 |
Intercompany payable | — |  |  | — |  |  | 66.0 |  |  | 4.4 |  |  | (70.4 | ) |  | — |
| 2,901.0 |  |  | 669.0 |  |  | 434.8 |  |  | 1,041.7 |  |  | (898.5 | ) |  | 4,148.0 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 31.4 |  |  | 208.2 |  |  | — |  |  | 239.6 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,352.2 |  |  | 2,703.5 |  |  | 568.9 |  |  | 336.0 |  |  | (3,608.4 | ) |  | 1,352.2 |
Noncontrolling interests | — |  |  | — |  |  | 340.9 |  |  | — |  |  | — |  |  | 340.9 |
Total shareholders’ equity | 1,352.2 |  |  | 2,703.5 |  |  | 909.8 |  |  | 336.0 |  |  | (3,608.4 | ) |  | 1,693.1 |
Total liabilities and shareholders’ equity | $ | 4,253.2 |  |  | $ | 3,372.5 |  |  | $ | 1,376.0 |  |  | $ | 1,585.9 |  |  | $ | (4,506.9 | ) |  | $ | 6,080.7 |
| As of December 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 5.1 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 69.2 |
Restricted cash | — |  |  | — |  |  | 59.0 |  |  | — |  |  | — |  |  | 59.0 |
Accounts receivable | — |  |  | 270.7 |  |  | 121.6 |  |  | 75.4 |  |  | — |  |  | 467.7 |
Prepaid expenses and other current assets | 36.3 |  |  | 17.6 |  |  | 26.2 |  |  | 4.9 |  |  | (18.8 | ) |  | 66.2 |
Total current assets | 77.8 |  |  | 291.3 |  |  | 211.9 |  |  | 99.9 |  |  | (18.8 | ) |  | 662.1 |
Property and equipment, net | 123.9 |  |  | 1,041.5 |  |  | 445.2 |  |  | 24.2 |  |  | — |  |  | 1,634.8 |
Goodwill | — |  |  | 912.2 |  |  | 293.3 |  |  | 895.3 |  |  | — |  |  | 2,100.8 |
Intangible assets, net | 21.4 |  |  | 96.6 |  |  | 67.5 |  |  | 257.9 |  |  | — |  |  | 443.4 |
Deferred income tax assets | 47.9 |  |  | 28.9 |  |  | 0.1 |  |  | — |  |  | (34.0 | ) |  | 42.9 |
Other long-term assets | 47.9 |  |  | 100.4 |  |  | 130.9 |  |  | 11.8 |  |  | — |  |  | 291.0 |
Intercompany notes receivable | 535.3 |  |  | — |  |  | — |  |  | — |  |  | (535.3 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,904.4 |  |  | 457.6 |  |  | — |  |  | — |  |  | (3,362.0 | ) |  | — |
Total assets | $ | 3,758.6 |  |  | $ | 2,928.5 |  |  | $ | 1,148.9 |  |  | $ | 1,289.1 |  |  | $ | (3,950.1 | ) |  | $ | 5,175.0 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 35.0 |  |  | $ | 7.5 |  |  | $ | 4.4 |  |  | $ | 6.4 |  |  | $ | (17.5 | ) |  | $ | 35.8 |
Accounts payable | 8.9 |  |  | 46.4 |  |  | 30.4 |  |  | 4.3 |  |  | — |  |  | 90.0 |
Accrued payroll | 35.0 |  |  | 69.1 |  |  | 35.4 |  |  | 48.9 |  |  | — |  |  | 188.4 |
Accrued interest payable | 22.3 |  |  | 2.4 |  |  | — |  |  | — |  |  | (0.3 | ) |  | 24.4 |
Other current liabilities | 154.5 |  |  | 5.1 |  |  | 85.7 |  |  | 89.6 |  |  | (1.0 | ) |  | 333.9 |
Total current liabilities | 255.7 |  |  | 130.5 |  |  | 155.9 |  |  | 149.2 |  |  | (18.8 | ) |  | 672.5 |
Long-term debt, net of current portion | 2,188.7 |  |  | 262.1 |  |  | 20.0 |  |  | 7.8 |  |  | — |  |  | 2,478.6 |
Intercompany notes payable | — |  |  | — |  |  | — |  |  | 535.3 |  |  | (535.3 | ) |  | — |
Self-insured risks | 16.1 |  |  | — |  |  | 103.5 |  |  | — |  |  | — |  |  | 119.6 |
Other long-term liabilities | 21.4 |  |  | 17.1 |  |  | 5.0 |  |  | 76.0 |  |  | (33.9 | ) |  | 85.6 |
Intercompany payable | — |  |  | — |  |  | 48.9 |  |  | 4.2 |  |  | (53.1 | ) |  | — |
| 2,481.9 |  |  | 409.7 |  |  | 333.3 |  |  | 772.5 |  |  | (641.1 | ) |  | 3,356.3 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 38.3 |  |  | 223.4 |  |  | — |  |  | 261.7 |
Shareholders’ equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,276.7 |  |  | 2,518.8 |  |  | 497.0 |  |  | 293.2 |  |  | (3,309.0 | ) |  | 1,276.7 |
Noncontrolling interests | — |  |  | — |  |  | 280.3 |  |  | — |  |  | — |  |  | 280.3 |
Total shareholders’ equity | 1,276.7 |  |  | 2,518.8 |  |  | 777.3 |  |  | 293.2 |  |  | (3,309.0 | ) |  | 1,557.0 |
Total liabilities and shareholders’ equity | $ | 3,758.6 |  |  | $ | 2,928.5 |  |  | $ | 1,148.9 |  |  | $ | 1,289.1 |  |  | $ | (3,950.1 | ) |  | $ | 5,175.0 |
Condensed Consolidating Statement of Cash Flows |
| For the Year Ended December 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash (used in) provided by operating activities | $ | (110.8 | ) |  | $ | 450.3 |  |  | $ | 247.9 |  |  | $ | 47.9 |  |  | $ | — |  |  | $ | 635.3 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of businesses, net of cash acquired | (217.8 | ) |  | — |  |  | — |  |  | (13.7 | ) |  | — |  |  | (231.5 | )
Purchases of property and equipment | (38.6 | ) |  | (207.3 | ) |  | (117.9 | ) |  | (8.6 | ) |  | — |  |  | (372.4 | )
Additions to capitalized software costs | (7.4 | ) |  | (0.7 | ) |  | (1.4 | ) |  | (3.5 | ) |  | — |  |  | (13.0 | )
Purchases of intangible assets | — |  |  | (18.0 | ) |  | — |  |  | (0.7 | ) |  | — |  |  | (18.7 | )
Proceeds from sale of restricted investments | — |  |  | — |  |  | 17.6 |  |  | — |  |  | — |  |  | 17.6 |
Purchases of restricted investments | — |  |  | — |  |  | (30.9 | ) |  | (2.0 | ) |  | — |  |  | (32.9 | )
Funding of intercompany note receivable | (64.0 | ) |  | — |  |  | — |  |  | — |  |  | 64.0 |  |  | — |
Proceeds from repayment of intercompany note receivable | 93.0 |  |  | — |  |  | 17.5 |  |  | — |  |  | (110.5 | ) |  | — |
Other, net | (8.3 | ) |  | 8.2 |  |  | (6.7 | ) |  | 0.3 |  |  | — |  |  | (6.5 | )
Net cash provided used in investing activities | (243.1 | ) |  | (217.8 | ) |  | (121.8 | ) |  | (28.2 | ) |  | (46.5 | ) |  | (657.4 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from bond issuance | 1,000.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,000.0 |
Principal payments on debt, including pre-payments | (517.8 | ) |  | — |  |  | (1.7 | ) |  | — |  |  | — |  |  | (519.5 | )
Principal borrowings on intercompany note payable | — |  |  | — |  |  | — |  |  | 64.0 |  |  | (64.0 | ) |  | — |
Principal payments on intercompany note payable | (17.5 | ) |  | — |  |  | — |  |  | (93.0 | ) |  | 110.5 |  |  | — |
Borrowings on revolving credit facility | 635.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 635.0 |
Payments on revolving credit facility | (620.0 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (620.0 | )
Principal payments under finance lease obligations | (0.7 | ) |  | (8.3 | ) |  | (2.6 | ) |  | (7.9 | ) |  | — |  |  | (19.5 | )
Debt amendment and issuance costs | (21.5 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (21.5 | )
Repurchases of common stock, including fees and expenses | (45.9 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (45.9 | )
Dividends paid on common stock | (108.6 | ) |  | — |  |  | — |  |  | (0.1 | ) |  | — |  |  | (108.7 | )
Purchase of equity interests in consolidated affiliates | (162.9 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (162.9 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (79.8 | ) |  | — |  |  | — |  |  | (79.8 | )
Taxes paid on behalf of employees for shares withheld | (15.4 | ) |  | — |  |  | — |  |  | (1.2 | ) |  | — |  |  | (16.6 | )
Contributions from consolidated affiliates | — |  |  | — |  |  | 15.9 |  |  | — |  |  | — |  |  | 15.9 |
Other, net | (4.4 | ) |  | — |  |  | — |  |  | (3.9 | ) |  | — |  |  | (8.3 | )
Change in intercompany advances | 245.8 |  |  | (222.0 | ) |  | (56.5 | ) |  | 32.7 |  |  | — |  |  | — |
Net cash provided by (used in) financing activities | 366.1 |  |  | (230.3 | ) |  | (124.7 | ) |  | (9.4 | ) |  | 46.5 |  |  | 48.2 |
Increase in cash, cash equivalents, and restricted cash | 12.2 |  |  | 2.2 |  |  | 1.4 |  |  | 10.3 |  |  | — |  |  | 26.1 |
Cash, cash equivalents, and restricted cash at beginning of year | 41.5 |  |  | 3.0 |  |  | 69.4 |  |  | 19.6 |  |  | — |  |  | 133.5 |
Cash, cash equivalents and restricted cash at end of year | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 70.8 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 159.6 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 5.1 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 69.2 |
Restricted cash at beginning of period | — |  |  | — |  |  | 59.0 |  |  | — |  |  | — |  |  | 59.0 |
Restricted cash included in other long-term assets at beginning of period | — |  |  | — |  |  | 5.3 |  |  | — |  |  | — |  |  | 5.3 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 69.4 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 133.5 |
Cash and cash equivalents at end of period | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 6.0 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 94.8 |
Restricted cash at end of period | — |  |  | — |  |  | 57.4 |  |  | — |  |  | — |  |  | 57.4 |
Restricted cash included in other long-term assets at end of period | — |  |  | — |  |  | 7.4 |  |  | — |  |  | — |  |  | 7.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 70.8 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 159.6 |
Supplemental schedule of noncash financing activity: |  |  |  |  |  |  |  |  |  |  |
Intercompany note activity | $ | (232.9 | ) |  | $ | — |  |  | $ | — |  |  | $ | 232.9 |  |  | $ | — |  |  | $ | — |
| For the Year Ended December 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash (used in) provided by operating activities | $ | (11.3 | ) |  | $ | 422.2 |  |  | $ | 259.0 |  |  | $ | 92.5 |  |  | $ | — |  |  | $ | 762.4 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of businesses, net of cash acquired | (131.4 | ) |  | — |  |  | — |  |  | (12.5 | ) |  | — |  |  | (143.9 | )
Purchases of property and equipment | (34.1 | ) |  | (133.9 | ) |  | (79.9 | ) |  | (6.6 | ) |  | — |  |  | (254.5 | )
Additions to capitalized software costs | (14.1 | ) |  | (0.1 | ) |  | — |  |  | (1.8 | ) |  | — |  |  | (16.0 | )
Purchases of intangible assets | (2.5 | ) |  | — |  |  | (0.1 | ) |  | (3.1 | ) |  | — |  |  | (5.7 | )
Proceeds from sale of restricted investments | — |  |  | — |  |  | 11.6 |  |  | — |  |  | — |  |  | 11.6 |
Purchases of restricted investments | — |  |  | — |  |  | (13.3 | ) |  | — |  |  | — |  |  | (13.3 | )
Proceeds from repayment of intercompany note receivable | 87.0 |  |  | — |  |  | — |  |  | — |  |  | (87.0 | ) |  | — |
Other, net | (6.0 | ) |  | 2.8 |  |  | — |  |  | 0.5 |  |  | — |  |  | (2.7 | )
Net cash used in investing activities | (101.1 | ) |  | (131.2 | ) |  | (81.7 | ) |  | (23.5 | ) |  | (87.0 | ) |  | (424.5 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on debt, including pre-payments | (17.6 | ) |  | — |  |  | (3.0 | ) |  | — |  |  | — |  |  | (20.6 | )
Principal payments on intercompany notes payable | — |  |  | — |  |  | — |  |  | (87.0 | ) |  | 87.0 |  |  | — |
Borrowings on revolving credit facility | 325.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 325.0 |
Payments on revolving credit facility | (390.0 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (390.0 | )
Principal payments under finance lease obligations | — |  |  | (8.4 | ) |  | (4.2 | ) |  | (5.3 | ) |  | — |  |  | (17.9 | )
Debt amendment and issuance costs | — |  |  | — |  |  | (0.1 | ) |  | — |  |  | — |  |  | (0.1 | )
Dividends paid on common stock | (100.7 | ) |  | — |  |  | — |  |  | (0.1 | ) |  | — |  |  | (100.8 | )
Purchase of equity interests in consolidated affiliates | (65.1 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (65.1 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (75.4 | ) |  | — |  |  | — |  |  | (75.4 | )
Taxes paid on behalf of employees for shares withheld | (7.4 | ) |  | — |  |  | — |  |  | (0.9 | ) |  | — |  |  | (8.3 | )
Contributions from consolidated affiliates | — |  |  | — |  |  | 12.6 |  |  | — |  |  | — |  |  | 12.6 |
Other, net | 3.0 |  |  | — |  |  | 13.2 |  |  | 3.2 |  |  | — |  |  | 19.4 |
Change in intercompany advances | 372.4 |  |  | (282.5 | ) |  | (118.9 | ) |  | 29.0 |  |  | — |  |  | — |
Net cash provided by (used in) financing activities | 119.6 |  |  | (290.9 | ) |  | (175.8 | ) |  | (61.1 | ) |  | 87.0 |  |  | (321.2 | )
Increase in cash, cash equivalents, and restricted cash | 7.2 |  |  | 0.1 |  |  | 1.5 |  |  | 7.9 |  |  | — |  |  | 16.7 |
Cash, cash equivalents, and restricted cash at beginning of year | 34.3 |  |  | 2.9 |  |  | 67.9 |  |  | 11.7 |  |  | — |  |  | 116.8 |
Cash, cash equivalents, and restricted cash at end of year | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 69.4 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 133.5 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 5.5 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash at beginning of period | — |  |  | — |  |  | 62.4 |  |  | — |  |  | — |  |  | 62.4 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 67.9 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 116.8 |
Cash and cash equivalents at end of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 5.1 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 69.2 |
Restricted cash at end of period | — |  |  | — |  |  | 59.0 |  |  | — |  |  | — |  |  | 59.0 |
Restricted cash included in other long-term assets at end of period | — |  |  | — |  |  | 5.3 |  |  | — |  |  | — |  |  | 5.3 |
Cash, cash equivalents, and restricted cash at end of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 69.4 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 133.5 |
Supplemental schedule of noncash investing activities: |  |  |  |  |  |  |  |  |  |  |
Intercompany note activity | $ | (136.8 | ) |  | $ | — |  |  | $ | — |  |  | $ | 136.8 |  |  | $ | — |  |  | $ | — |
| For the Year Ended December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 28.2 |  |  | $ | 385.9 |  |  | $ | 181.2 |  |  | $ | 63.0 |  |  | $ | — |  |  | $ | 658.3 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of businesses, net of cash acquired | (10.9 | ) |  | — |  |  | — |  |  | (27.9 | ) |  | — |  |  | (38.8 | )
Purchases of property and equipment | (39.4 | ) |  | (106.5 | ) |  | (75.4 | ) |  | (4.5 | ) |  | — |  |  | (225.8 | )
Additions to capitalized software costs | (16.3 | ) |  | (0.3 | ) |  | (0.1 | ) |  | (2.5 | ) |  | — |  |  | (19.2 | )
Purchases of intangible assets | — |  |  | — |  |  | — |  |  | (3.7 | ) |  | — |  |  | (3.7 | )
Proceeds from sale of restricted investments | — |  |  | — |  |  | 4.2 |  |  | — |  |  | — |  |  | 4.2 |
Purchases of restricted investments | — |  |  | — |  |  | (8.5 | ) |  | — |  |  | — |  |  | (8.5 | )
Proceeds from repayment of intercompany note receivable | 51.0 |  |  | — |  |  | — |  |  | — |  |  | (51.0 | ) |  | — |
Other, net | (3.7 | ) |  | 11.7 |  |  | 0.2 |  |  | 0.6 |  |  | — |  |  | 8.8 |
Net cash used in investing activities | (19.3 | ) |  | (95.1 | ) |  | (79.6 | ) |  | (38.0 | ) |  | (51.0 | ) |  | (283.0 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on debt, including pre-payments | (126.9 | ) |  | — |  |  | (3.0 | ) |  | — |  |  | — |  |  | (129.9 | )
Principal payments on intercompany notes payable | — |  |  | — |  |  | — |  |  | (51.0 | ) |  | 51.0 |  |  | — |
Borrowings on revolving credit facility | 273.3 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 273.3 |
Payments on revolving credit facility | (330.3 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (330.3 | )
Principal payments under finance lease obligations | — |  |  | (7.3 | ) |  | (3.9 | ) |  | (4.1 | ) |  | — |  |  | (15.3 | )
Debt amendment and issuance costs | (4.1 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (4.1 | )
Repurchases of common stock, including fees and expenses | (38.1 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (38.1 | )
Dividends paid on common stock | (91.5 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (91.5 | )
Proceeds from exercising stock warrants | 26.6 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 26.6 |
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (51.9 | ) |  | — |  |  | — |  |  | (51.9 | )
Taxes paid on behalf of employees for shares withheld | (19.5 | ) |  | — |  |  | — |  |  | (0.3 | ) |  | — |  |  | (19.8 | )
Contributions from consolidated affiliates | — |  |  | — |  |  | 20.8 |  |  | — |  |  | — |  |  | 20.8 |
Other, net | 1.0 |  |  | — |  |  | — |  |  | (0.7 | ) |  | — |  |  | 0.3 |
Change in intercompany advances | 314.3 |  |  | (282.2 | ) |  | (62.0 | ) |  | 29.9 |  |  | — |  |  | — |
Net cash provided by (used in) financing activities | 4.8 |  |  | (289.5 | ) |  | (100.0 | ) |  | (26.2 | ) |  | 51.0 |  |  | (359.9 | )
Increase in cash, cash equivalents, and restricted cash | 13.7 |  |  | 1.3 |  |  | 1.6 |  |  | (1.2 | ) |  | — |  |  | 15.4 |
Cash, cash equivalents, and restricted cash at beginning of year | 20.6 |  |  | 1.6 |  |  | 66.3 |  |  | 12.9 |  |  | — |  |  | 101.4 |
Cash, cash equivalents, and restricted cash at end of year | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 67.9 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 116.8 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 5.4 |  |  | $ | 12.9 |  |  | $ | — |  |  | $ | 40.5 |
Restricted cash at beginning of period | — |  |  | — |  |  | 60.9 |  |  | — |  |  | — |  |  | 60.9 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 66.3 |  |  | $ | 12.9 |  |  | $ | — |  |  | $ | 101.4 |
Cash and cash equivalents at end of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 5.5 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash at end of period | — |  |  | — |  |  | 62.4 |  |  | — |  |  | — |  |  | 62.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 67.9 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 116.8 |
Supplemental schedule of noncash financing activities: |  |  |  |  |  |  |  |  |  |  |
Intercompany note activity | $ | (8.8 | ) |  | $ | — |  |  | $ | — |  |  | $ | 8.8 |  |  | $ | — |  |  | $ | — |
Conversion of convertible debt | 319.4 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 319.4 |

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration